Kintor Pharmaceutical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	32.68	5	-	-	34.23
Revenue	32.68	5	-	-	34.23
Revenue Growth (YoY)	553.64%	-	-	-	-
Cost of Revenue	24.64	3.52	1.13	-	-
Gross Profit	8.04	1.48	-1.13	-	34.23
Selling, General & Admin	96.11	88	93.38	152.58	117.95
Research & Development	87.27	71.49	849.71	827.97	767.94
Other Operating Expenses	-2.9	-17.43	-7.49	-11.43	-16.96
Operating Expenses	180.48	143.26	935.6	969.12	868.93
Operating Income	-172.44	-141.78	-936.73	-969.12	-834.7
Interest Expense	-3.94	-9.28	-9.69	-8.19	-2.49
Interest & Investment Income	-	4.21	13.08	6.88	12.05
Earnings From Equity Investments	0.77	-1.43	0.05	-0.57	-
Currency Exchange Gain (Loss)	-0.04	3.73	-3.13	16.33	-17.63
EBT Excluding Unusual Items	-175.66	-144.55	-936.42	-954.67	-842.77
Gain (Loss) on Sale of Investments	-	0	0.49	2	0.78
Gain (Loss) on Sale of Assets	-0.06	2.52	0.01	-0.62	-0.11
Asset Writedown	-27.24	-13.25	-132.94	-	-
Pretax Income	-202.96	-155.27	-1,069	-953.28	-842.1
Income Tax Expense	-2.85	0.02	-8.04	1.09	-
Net Income	-200.11	-155.29	-1,061	-954.37	-842.1
Net Income to Common	-200.11	-155.29	-1,061	-954.37	-842.1
Shares Outstanding (Basic)	450	431	429	377	356
Shares Outstanding (Diluted)	450	431	429	377	356
Shares Change (YoY)	4.42%	0.39%	13.94%	5.66%	15.21%
EPS (Basic)	-0.44	-0.36	-2.47	-2.53	-2.36
EPS (Diluted)	-0.44	-0.36	-2.47	-2.53	-2.36
Free Cash Flow	-170.44	-200.62	-390.3	-988.73	-1,128
Free Cash Flow Per Share	-0.38	-0.47	-0.91	-2.63	-3.16
Gross Margin	24.60%	29.56%	-	-	100.00%
Operating Margin	-527.63%	-2835.64%	-	-	-2438.42%
Profit Margin	-612.28%	-3105.84%	-	-	-2460.04%
Free Cash Flow Margin	-521.50%	-4012.36%	-	-	-3294.09%
EBITDA	-140.66	-128.63	-922.88	-956.45	-827.97
D&A For EBITDA	31.79	13.15	13.85	12.68	6.73
EBIT	-172.44	-141.78	-936.73	-969.12	-834.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.